Analytical Data
-
Gene name
LUZP4
- Application
-
Alternative Names
Cancer/testis antigen 28; CT 8; CT-28; CT28; ENSMUSG00000072927; HOM TES 85; HOM TES 85 tumor antigen; Leucine zipper protein 4; LUZP4; LUZP4_HUMAN; OTTHUMP00000023875; RP1-237H22.1; RP23-463M4.2; Tumor antigen HOM-TES-85
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9P127
-
Expression Region
1-313aa
-
AA Sequence
MASFRKLTLSEKVPPNHPSRKKVNFLDMSLDDIIIYKELEGTNAEEEKNKRQNHSKKESPSRQQSKAHRHRHRRDYSRCRSNSEEGNHDKKPSQKPSGFKSGQHPLNGQPLIEQEKCSDNYEAQAEKNQGQSEGNQHQSEGNPDKSEESQGQPEENHHSERSRNHLERSLSQSDRSQGQLKRHHPQYERSHGQYKRSHGQSERSHGHSERSHGHSERSHGHSERSHGHSKRSRSQGDLVDTQSDLIATQRDLIATQKDLIATQRDLIATQRDLIVTQRDLVATERDLINQSGRSHGQSERHQRYSTGKNTITT
-
Molecular Weight
60.83 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LUZP4, a member of the LUZP family of proteins, has garnered attention in recent biomedical research due to its potential role in various physiological and pathological processes. Initially identified through bioinformatics screening and expression profiling, LUZP4 is believed to be involved in cellular signaling pathways and immune responses. Its expression patterns suggest a link to certain disease states, including cancer and autoimmune disorders. Recent studies have indicated that LUZP4 may interact with key proteins involved in cell differentiation, proliferation, and apoptosis, thus highlighting its significance in maintaining cellular homeostasis. Researchers are particularly interested in elucidating the molecular mechanisms underlying LUZP4’s function, including its structural features and interaction networks. The development of recombinant LUZP4 proteins has facilitated the investigation of its functional properties, enabling assays to assess its role in cellular contexts. Furthermore, understanding LUZP4's biochemical characteristics could provide insights into its potential as a therapeutic target or biomarker in disease management. Despite the growing body of research, many aspects of LUZP4's function and regulation remain elusive, underscoring the necessity for continued exploration into its biological significance and therapeutic potential. As such, LUZP4 presents a promising avenue for future studies aimed at deciphering its role in health and disease.
